Mutant huntingtin-mediated protein dysfunction
US10525108B2 · kind B2 · utility
0Cited by
0References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 17, 2016 |
| Grant date | Jan 7, 2020 |
| Priority date | — |
| Expiry date | Nov 20, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y207/11001
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods of inhibiting neurodegeneration in a subject suffering from or genetically at risk and/or destined to develop Huntington's Disease comprising increasing, in neurons of the subject, the activity of the TIM23 mitochondrial protein import complex.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.